Status:
UNKNOWN
Evaluation of an Electronic Health Record-based Screening Tool for Peripheral Artery Disease
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Peripheral Artery Disease
Peripheral Vascular Disease
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
This protocol represents a pilot randomized-controlled trial evaluating the effect of an electronic health record (EHR)-based peripheral artery disease (PAD) screening tool on rates of new non-invasiv...
Eligibility Criteria
Inclusion
- Are 50-85 years old
- Currently an outpatient, actively obtaining care at Stanford
- Have at least 1 year of data within the Stanford EHR (including at least 2 clinical visits)
- Have no prior diagnosis of peripheral artery disease as determined by no chart term mentions or ICD-9/10 codes in their EHR data
Exclusion
- Have less than 1 year of data available or less than 2 clinical visits at Stanford
- Enrolled in a previous related study
- Receiving treatment for a potentially terminal condition
- Prior diagnosis of peripheral artery disease by ICD code or term mention in their EHR data.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04054232
Start Date
December 1 2023
End Date
June 1 2024
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305